4 ms·
It can't "kill" Siri because IBM will never be able to integrate it as tightly with iOS due to App Store restrictions. Sorry IBM! That's what you get for build
by bishnu 14y ago
It can't "kill" Siri because IBM will never be able to integrate it as tightly with iOS due to App Store restrictions. Sorry IBM! That's what you get for building a product instead of a platform.
- StavrosK 14y agoAndroid.
- pooriaazimi 14y agoThey make a deal with Apple and get paid handsomely because of that. An ad-supported app has to be on many devices, and to be run a very long time to be worth $100 million dollars or so (that's probably how much the deal would cost for Apple).
- jlgreco 14y agoExactly, this is the IBM of the 21st century we are talking about. They don't make their money by doing business with people, they are all about research and contracting for companies now.
- jonknee 14y agoIBM isn't interested in $100M. The article plainly states they're going after billions. > Finding additional uses for Watson is part of IBM’s plan to tap new markets and boost revenue from business analytics to $16 billion by 2015. > IBM expects to generate billions in sales by putting Watson to work in finance, health care, telecommunications and other areas.
- jonknee 14y agoYou must not have read the article. It was not about having a service running two home-screen button taps away from all iPhone users that is also better than Siri. It was about being able to sell a service to businesses with similar AI features as Siri but that provides useful information in specialized fields. This was very obvious if you read any of the article. > IBM expects to generate billions in sales by putting Watson to work in finance, health care, telecommunications and other areas > IBM’s path to the mobile-assistant market contrasts with Apple’s. For one, IBM is focused on corporate customers, while Apple is targeting anyone who buys its phones. > The program will be able to understand oncology well enough to advise doctors on diagnosis and prescriptions, said Martin Kohn, IBM’s chief medical scientist. One iPad application for Watson -- a health-care program developed with a Columbia University professor -- is being used to demonstrate its medical capabilities for prospective IBM customers